Mr Pissanu says JSP plans to export its branded and functional FMCG products to China.
JSP Pharmaceutical Manufacturing (Thailand) Plc is responding to growing demand for wellness products by expanding into international markets, strengthening its own brand and adding fast-moving consumer goods (FMCG) to its portfolio.Thailand's dietary supplement market was estimated at US$2.78 billion in 2025 and is projected to reach $5.76 billion in 2033, growing at a compound annual growth rate of 9.6% from 2026-2033, according to Grandview Research.
Pissanu Daengprasert, chief executive of JSP, said the company will focus on producing and distributing products under its Suphap Osod brand, including supplements, to enhance the brand's credibility and support the launch of a new brand later this year.
The company also wants to expand internationally, with a focus on China, Southeast Asia, Taiwan and the Middle East.
Mr Pissanu said China is the most promising market, and the company plans to export its branded products and functional FMCG products there.
